BPC-157 + TB-500 Research Blend – 20 mg Total

BPC-157 + TB-500 Research Blend – 20 mg Total is a dual-peptide research formulation supplied in a high-content 20 mg vial for controlled laboratory, analytical, and scientific investigations.

The formulation combines BPC-157 with TB-500-related research material, allowing both peptide systems to be investigated within a single laboratory formulation.

BPC-157 is a synthetic peptide commonly investigated in experimental studies involving cellular signaling and tissue-response-related pathways. TB-500 is commonly associated with thymosin beta-4-related peptide research, including experimental investigations involving actin interactions, cytoskeletal processes, and cellular migration.

The combined formulation provides a research material suitable for appropriately designed experiments examining multi-peptide interactions, comparative biochemical responses, compound characterization, and analytical behavior.

This product is supplied exclusively for laboratory research and analytical purposes. It is not intended for human consumption, veterinary administration, diagnosis, or medical treatment.

Product Specifications

• Product name: BPC-157 + TB-500 Research Blend
• Compounds: BPC-157 and TB-500
• Total content: 20 mg per vial
• Compound category: Dual-peptide research blend
• Research focus: Multi-peptide signaling and comparative peptide research
• Documentation: Certificate of Analysis available
• Available quantities: 1, 3, 5, 10, or 20 vials
• Shipping origin: United States
• Delivery: Domestic US-to-US shipping
• Intended purpose: Laboratory research and analytical testing only

The exact BPC-157-to-TB-500 ratio should be confirmed from the applicable product formulation and batch-specific Certificate of Analysis. A 20 mg total-content statement alone does not establish how the material is divided between the individual peptide components.

Dual-Peptide Research Characteristics

The BPC-157 + TB-500 blend brings together two research compounds associated with different areas of experimental peptide investigation.

BPC-157 research has examined cellular signaling, peptide interactions, cellular-response pathways, and other biochemical processes in experimental models.

TB-500-related research is commonly associated with thymosin beta-4-related peptide biology and laboratory investigations involving actin interactions, cytoskeletal organization, and cell-migration pathways.

A combined research formulation may therefore be useful for controlled investigations examining how multiple peptide materials behave within the same experimental system.

Potential areas of laboratory investigation include:

• Multi-peptide interaction studies
• Cellular signaling research
• Cell-migration pathways
• Cytoskeletal research
• Actin-related biochemical investigations
• Peptide-cell interaction studies
• Comparative peptide analysis
• Combined-compound characterization
• Analytical testing
• Stability and degradation analysis
• Research method development

These subjects describe areas of scientific investigation only. They should not be interpreted as claims that this blend accelerates healing, repairs injuries, improves recovery, regenerates tissue, enhances athletic performance, or provides therapeutic benefits.

BPC-157 Research Component

BPC-157 is a synthetic peptide used in experimental laboratory research.

Published preclinical research has examined BPC-157 in connection with various cellular and biochemical processes. Experimental findings, however, should not be interpreted as established clinical effects or approval for personal use.

Within this blend, BPC-157 provides one component for comparative and multi-peptide laboratory investigations.

The exact identity and analytical characteristics of the material should always be verified using the applicable batch-specific documentation.

TB-500 Research Component

TB-500 is commonly marketed and investigated in connection with thymosin beta-4-related peptide research.

Research involving thymosin beta-4 has examined interactions with actin and various cellular processes. However, researchers should not automatically treat TB-500 and full-length thymosin beta-4 as chemically interchangeable.

The exact identity and specifications of the TB-500 component should therefore be established using the batch-specific Certificate of Analysis and product documentation.

This distinction is especially important when comparing laboratory findings obtained with TB-500 against published research involving full-length thymosin beta-4.

Combined Peptide Research

The defining characteristic of this product is the presence of BPC-157 and TB-500 research materials within a single formulation.

A combined format may be useful for appropriately designed laboratory investigations involving:

• Combined peptide characterization
• Multi-compound analytical testing
• Comparative signaling studies
• Peptide interaction experiments
• Stability analysis
• Controlled multi-peptide studies
• Repeat experimental series
• Analytical method development

Researchers should account for the presence of both peptide components when designing experimental controls and interpreting analytical results.

High-Content 20 mg Research Format

The 20 mg presentation contains twice the nominal total research material of the corresponding 10 mg BPC-157 + TB-500 blend.

This higher-content format may be useful for research projects requiring:

• Larger quantities of research material
• Multiple analytical samples
• Replicate experiments
• Comparative studies
• Larger experimental series
• Stability testing
• Compound characterization
• Analytical method development

Researchers should select the appropriate quantity according to their experimental objectives and validated laboratory protocols.

COA-Confirmed Research Material

BPC-157 + TB-500 Research Blend – 20 mg is supplied with access to batch-specific Certificate of Analysis (COA) documentation.

Depending on the analytical testing performed for the applicable batch, documentation may include:

• Compound identification
• BPC-157 component identification
• TB-500 component identification
• Batch or lot number
• Stated formulation
• Tested purity
• Analytical testing methodology
• Laboratory test date
• Reported analytical results

Researchers should review the applicable Certificate of Analysis before beginning an experiment.

The batch-specific documentation should be considered the controlling source for the exact identity, composition, ratio, specifications, and analytical results associated with an individual lot.

Available Multi-Vial Options

BPC-157 + TB-500 Research Blend – 20 mg is available in several quantity options:

• 1 Vial – Regular Price
• 3 Vials – 5% OFF
• 5 Vials – 10% OFF ★ Most Popular ★
• 10 Vials – 15% OFF
• 20 Vials – 20% OFF

Each vial contains 20 mg total research material, distributed between BPC-157 and TB-500 according to the specified formulation.

Multi-vial packages provide a lower effective price per vial and may be suitable for projects requiring multiple samples, replicate experiments, comparative testing, or larger quantities from the same product specification.

Storage and Laboratory Handling

Store the BPC-157 + TB-500 research blend according to the conditions specified on the product label, packaging, and applicable batch documentation.

General laboratory precautions include:

• Keep the vial securely sealed until required
• Protect the material from excessive heat and direct light
• Avoid unnecessary temperature fluctuations
• Protect against moisture and contamination
• Use clean laboratory equipment and appropriate handling procedures
• Maintain accurate batch and lot records
• Document storage conditions and handling history
• Follow batch-specific storage requirements
• Minimize unnecessary handling of the material

Exact storage requirements should always be confirmed using the documentation supplied with the applicable batch.

Laboratory Use and Research Responsibility

BPC-157 + TB-500 Research Blend – 20 mg should be handled by qualified individuals familiar with laboratory procedures and research peptide management.

The purchaser is responsible for appropriate acquisition, storage, handling, documentation, experimental use, and disposal in accordance with applicable regulations and institutional requirements.

BuyGenerics does not provide instructions for personal administration, dosage recommendations, injection protocols, clinical treatment, injury recovery, athletic-performance use, or therapeutic applications.

Domestic US Shipping

BPC-157 + TB-500 Research Blend – 20 mg is available with domestic US-to-US fulfillment.

Ordering benefits include fast domestic delivery, discreet packaging, tracked shipping options, multiple vial quantities, and quantity discounts of up to 20%.

Domestic fulfillment also avoids international customs processing associated with overseas shipments.

Shipping availability and delivery times may vary depending on destination, inventory availability, order size, and selected delivery service.

Frequently Asked Questions

What compounds are included in this research blend?

The formulation contains BPC-157 and TB-500 research material.

How much material is contained in each vial?

Each vial contains 20 mg total research material.

Does 20 mg mean 20 mg of each peptide?

No. The 20 mg designation refers to the total stated content of the blend, not necessarily 20 mg of each component. The exact amount of BPC-157 and TB-500 should be confirmed from the product formulation and batch-specific COA.

What is the difference between the 10 mg and 20 mg blends?

The stated combination is the same, while the nominal total quantity per vial differs. The 20 mg presentation contains twice the total research material of the corresponding 10 mg blend.

Why combine BPC-157 and TB-500?

A combined formulation enables appropriately designed laboratory investigations involving both peptide materials under the same experimental conditions, including comparative, interaction, and multi-peptide analytical studies.

Is a Certificate of Analysis available?

Yes. Batch-specific Certificate of Analysis documentation is available. Researchers should review the applicable COA for exact composition, identity, specifications, and reported analytical results.

Can I purchase multiple vials?

Yes. Available package quantities include 1, 3, 5, 10, and 20 vials, with increasing quantity discounts.

Is this research blend intended for human use?

No. This product is sold exclusively for laboratory research and analytical applications and is not intended for human consumption or administration.

Research-Use Disclaimer

BPC-157 + TB-500 Research Blend – 20 mg is intended exclusively for laboratory research, analytical testing, and scientific investigation.

This product is not for human consumption or administration, veterinary use, use as a dietary supplement, athletic or performance use, diagnosis, treatment, or prevention of disease.

Information presented on this product page is provided solely for product identification and research-catalog purposes. It does not constitute medical advice, prescribing information, dosage guidance, injection instructions, or instructions for administration.